secwatch.observer — SEC 8-K summary
======================================

Issuer:     INCYTE CORP (INCY)
CIK:        0000879169
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0000879169-25-000059
Event type: litigation
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Incyte settles JAKAFI royalty dispute with Novartis; pays $280M vs $537M accrued
--------------------------------------------------------------------------------

- Settlement resolves litigation over royalty duration under 2009 Collaboration and License Agreement.
- Incyte to pay Novartis $280M; had $537.1M accrued as of March 31, 2025.
- Royalty rate on future U.S. JAKAFI net sales reduced by 50% effective Jan 1, 2025.
- Reduced royalty for Q1 2025 is ~$14.9M; $242.2M difference to be recorded in Q2 2025.
- Settlement eliminates contingent liability and lowers future royalty expense.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879169/000087916925000059/0000879169-25-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879169/000087916925000059/incy-20250511.htm
  HTML page:      https://secwatch.observer/filing/0000879169-25-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer